Serum immune response to Shigella protein antigens in rhesus monkeys and humans infected with Shigella spp
about
Type III protein secretion systems in bacterial pathogens of animals and plantsSurface presentation of Shigella flexneri invasion plasmid antigens requires the products of the spa locus.Identification and characterization of B-cell epitopes of IpaC, an invasion-associated protein of Shigella flexneri.Sequence and molecular characterization of a multicopy invasion plasmid antigen gene, ipaH, of Shigella flexneri.Immunoproteome analysis of soluble and membrane proteins of Shigella flexneri 2457T.Characterization of the Shigella flexneri ipgD and ipgF genes, which are located in the proximal part of the mxi locusCharacterization of B-cell epitopes on IpaB, an invasion-associated antigen of Shigella flexneri: identification of an immunodominant domain recognized during natural infection.Differential protein expression by Shigella flexneri in intracellular and extracellular environments.A challenge model for Shigella dysenteriae 1 in cynomolgus monkeys (Macaca fascicularis).Characterization of invasion plasmid antigen genes (ipaBCD) from Shigella flexneriIdentification of epitope and surface-exposed domains of Shigella flexneri invasion plasmid antigen D (IpaD)Identification of two Shigella flexneri chromosomal loci involved in intercellular spreading.Vaccination against shigellosis with attenuated Shigella flexneri 2a strain SC602Shigella flexneri 2a strain CVD 1207, with specific deletions in virG, sen, set, and guaBA, is highly attenuated in humans.Gut-Homing Conventional Plasmablasts and CD27(-) Plasmablasts Elicited after a Short Time of Exposure to an Oral Live-Attenuated Shigella Vaccine Candidate in Humans.Phase I evaluation of delta virG Shigella sonnei live, attenuated, oral vaccine strain WRSS1 in healthy adultsPurification, pore-forming ability, and antigenic relatedness of the major outer membrane protein of Shigella dysenteriae type 1.Construction and characterization of attenuated delta aroA delta virG Shigella flexneri 2a strain CVD 1203, a prototype live oral vaccineAntigen-specific IgA B memory cell responses to Shigella antigens elicited in volunteers immunized with live attenuated Shigella flexneri 2a oral vaccine candidates.Intracellular spread of Shigella flexneri associated with the kcpA locus and a 140-kilodalton proteinHuman milk immunoglobulin A antibodies to Shigella virulence determinants.Antibody and cytokine responses in a mouse pulmonary model of Shigella flexneri serotype 2a infection.Increased protein secretion and adherence to HeLa cells by Shigella spp. following growth in the presence of bile saltsRecognition of three epitopic regions on invasion plasmid antigen C by immune sera of rhesus monkeys infected with Shigella flexneri 2a.Induction of a local anti-IpaC antibody response in mice by use of a Shigella flexneri 2a vaccine candidate: implications for use of IpaC as a protein carrier.Engineered deltaguaB-A deltavirG Shigella flexneri 2a strain CVD 1205: construction, safety, immunogenicity, and potential efficacy as a mucosal vaccine.Immune response to Shigella sonnei in U.S. MarinesSafety, immunogenicity, and transmissibility in humans of CVD 1203, a live oral Shigella flexneri 2a vaccine candidate attenuated by deletions in aroA and virG.Nonpolar mutagenesis of the ipa genes defines IpaB, IpaC, and IpaD as effectors of Shigella flexneri entry into epithelial cellsGenetic analysis of an invasion region by use of a Tn3-lac transposon and identification of a second positive regulator gene, invE, for cell invasion of Shigella sonnei: significant homology of invE with ParB of plasmid P1.virG, a plasmid-coded virulence gene of Shigella flexneri: identification of the virG protein and determination of the complete coding sequenceMolecular cloning of invasion plasmid antigen (ipa) genes from Shigella flexneri: analysis of ipa gene products and genetic mapping.Monoclonal immunoglobulin A antibody directed against serotype-specific epitope of Shigella flexneri lipopolysaccharide protects against murine experimental shigellosisMolecular pathogenesis of Shigella spp.: controlling host cell signaling, invasion, and death by type III secretion.Co-administration of rIpaB domain of Shigella with rGroEL of S. Typhi enhances the immune responses and protective efficacy against Shigella infection.Identification of enteroinvasive Escherichia coli and Shigella strains in pediatric patients by an IpaC-specific enzyme-linked immunosorbent assayEvaluation of the Safety, Tolerability, and Immunogenicity of an Oral, Inactivated Whole-Cell Shigella flexneri 2a Vaccine in Healthy Adult Subjects.Clinical trials of Shigella vaccines: two steps forward and one step back on a long, hard road.Shigella antigen-specific B memory cells are associated with decreased disease severity in subjects challenged with wild-type Shigella flexneri 2a.Safety, immunogenicity, and efficacy in monkeys and humans of invasive Escherichia coli K-12 hybrid vaccine candidates expressing Shigella flexneri 2a somatic antigen.
P2860
Q24548602-337C3CF8-8B7B-4578-9E4E-AC2B2BD5CA4DQ30982682-C14329BC-8B66-42A2-9504-A2C7175E783BQ31169709-FF3708EF-0E62-4AF6-A1C5-32504C31FA19Q33253819-AEAE5B66-7D17-4FE3-86D0-61272050FDC6Q33262196-F06F9902-C810-48E2-84A3-9A616437CE91Q33594863-E15F705A-6034-4B25-89E4-EBDC90DB1682Q33608118-6F16A7BE-E50B-4DAC-BC6D-9D45BF1DF0B4Q33609143-4DD142B7-5524-41EF-BC24-BF80D1A12FC9Q33676706-7D80A904-B4E4-4BF4-89CA-126CB55F99FCQ33682684-6CD0BBC7-0032-4259-AC05-E7DBFE4E75C2Q33753646-C96709A3-5C1B-4F0F-B6C7-D75750B3239AQ33764731-432E2E7B-433A-45B7-A3BF-0828EE8388EAQ33876803-5F190F2E-9FA0-435E-8C23-A96BB8CEC0E8Q34003433-78E584B3-4D60-4436-979B-0CE8B46B2C54Q34068059-30150475-A934-4657-B4B6-7542CF3BFC4EQ34120926-68C04836-2CAF-4B38-AF54-5A78BBB4696DQ34540505-283B6C36-2CA8-4F08-8B90-C05C0579E07DQ34545910-FEBECB97-A6A1-4660-A18D-DE75D534C58CQ34809879-149CA205-D63E-4768-B340-684E0D9F45E0Q35090542-89B3B436-4C34-44CB-B5D5-173CDC7C9F55Q35096605-1B51E863-9902-46CD-92E1-D5AC0AE50478Q35411990-8FD77D6B-DCDF-4981-BE1E-B5A4CF65937FQ35439004-82756BB7-37D2-45F9-B8A4-978249A05CBFQ35443019-F0958768-57ED-42A8-A773-ED6B9F99A607Q35480510-6B45B3DD-726B-40B2-AE67-CB5B984167FFQ35510455-9E5DC09F-F899-4081-993B-74A99B4F2561Q35521181-EC294DCD-B1FC-4E5F-9683-971378CD832AQ35528270-F982C6CC-A2CB-40E0-863D-B76C50858046Q36122200-273BC0C5-4DA4-491E-901C-2D944D0DF9BBQ36157790-DE338319-27C2-40BD-A530-01E388515CD8Q36173163-F624526C-47BC-4A53-9B9A-1F2ABD0A2ABFQ36238161-644EF493-1307-4ADC-A416-09D88E8BB132Q36365336-73B8F00E-B7A2-4AEA-949A-5DB426343D5DQ36422508-1FC93EEA-E413-4CCE-A0E2-8397247E04FCQ36473218-6C3E2D68-F6D2-4BF4-ADCC-365360C9E949Q36545068-94D02389-120C-4DF8-A1E5-F3F871909B1FQ36764372-759A03FD-3D38-4262-AEA6-D42A77F9AD14Q36844719-7B94F8E8-FF62-4206-B266-1FC1B041B1C7Q36920244-508AC7FA-D179-4107-9EC0-18B927ED3A55Q36945836-B9810114-7AE4-4CC7-B60A-EEC69EAC1105
P2860
Serum immune response to Shigella protein antigens in rhesus monkeys and humans infected with Shigella spp
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on July 1986
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Serum immune response to Shige ...... ans infected with Shigella spp
@en
Serum immune response to Shige ...... ns infected with Shigella spp.
@nl
type
label
Serum immune response to Shige ...... ans infected with Shigella spp
@en
Serum immune response to Shige ...... ns infected with Shigella spp.
@nl
prefLabel
Serum immune response to Shige ...... ans infected with Shigella spp
@en
Serum immune response to Shige ...... ns infected with Shigella spp.
@nl
P2093
P2860
P1476
Serum immune response to Shige ...... ans infected with Shigella spp
@en
P2093
P2860
P407
P577
1986-07-01T00:00:00Z